Concord Wealth Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-54
| Closed | -$6.25K | – | 1060 |
|
|
2023
Q3 | $6.25K | Hold |
54
| – | – | ﹤0.01% | 686 |
|
|
2023
Q2 | $5.55K | Hold |
54
| – | – | ﹤0.01% | 687 |
|
|
2023
Q1 | $5.89K | Hold |
54
| – | – | ﹤0.01% | 650 |
|
|
2022
Q4 | $6.15K | Buy |
+54
| New | +$6.15K | ﹤0.01% | 717 |
|
|
2022
Q3 | – | Sell |
-54
| Closed | -$4K | – | 1280 |
|
|
2022
Q2 | $4K | Hold |
54
| – | – | ﹤0.01% | 912 |
|
|
2022
Q1 | $6K | Hold |
54
| – | – | ﹤0.01% | 889 |
|
|
2021
Q4 | $6K | Hold |
54
| – | – | ﹤0.01% | 923 |
|
|
2021
Q3 | $6K | Hold |
54
| – | – | ﹤0.01% | 569 |
|
|
2021
Q2 | $5K | Hold |
54
| – | – | ﹤0.01% | 751 |
|
|
2021
Q1 | $5K | Hold |
54
| – | – | ﹤0.01% | 692 |
|
|
2020
Q4 | $4K | Buy |
+54
| New | +$4K | ﹤0.01% | 451 |
|